詳細検索

詳細検索

お問い合わせ

Azenta Inc. (AZTA:NASD) - Strategic SWOT and Financial Analysis - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Financial and Operational KPIs, and Recent Trends

Azenta Inc. (AZTA:NASD) - Strategic SWOT and Financial Analysis - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Financial and Operational KPIs, and Recent Trends


Report Summary Azenta Inc. Strategic SWOT Analysis and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recen... もっと見る

 

 

出版社
Quaintel Research
クアインテルリサーチ
出版年月
2026年6月19日
電子版価格
納期
3-4営業日程度
ページ数
126
言語
英語

日本語のページはAI翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

Summary

Report Summary

Azenta Inc. Strategic SWOT Analysis and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report is a comprehensive and easily accessible overview of Azenta Inc.'s business operations. It provides a detailed analysis of the company's financial and strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company's performance.

The report begins with in-depth information about Azenta Inc. including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company's key attributes.

Next, the report assesses Azenta Inc.'s strategic standing through various analyses. The ESG spotlight evaluates the company's environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company's internal strengths and weaknesses, as well as external opportunities and threats. Additionally, By integrating these strategic analyses, the report offers a comprehensive understanding of Azenta Inc.'s overall strategic standing and supports informed decision-making and strategic planning.

The report also covers Azenta Inc.'s financial analysis basis of latest income statement, balance sheet, and cash flow statement. Key financial ratios related to profitability, asset turnover, credit, market, and long-term solvency are outlined, providing guidance for investment decisions. Furthermore, the report compares Azenta Inc.'s financial parameters with those of its competitors, offering a unique analysis of the competitive landscape. This information helps manage the business environment and improve sales activities by gaining insight into competitors' operations.

Finally, the report includes recent news and deal activities undertaken by Azenta Inc. enhancing awareness of the company's business trends, growth perspectives, and more.

Key Highlights

Azenta Inc., founded in 1978 and formerly known as Brooks Automation until its rebranding in December 2021, is a leading provider of innovative life sciences solutions. Headquartered at 200 Summit Drive in Burlington, Massachusetts, United States, the company drives advancements in sample management, automation, genomics, and cryogenic storage to accelerate scientific discoveries and therapies. Operating primarily in the healthcare sector specifically medical instruments and supplies Azenta delivers products and services across two key segments: Life Sciences Products and Life Sciences Services. These offerings support experimental design, gene sequencing, sample analysis, and consultation for biotech and pharmaceutical clients worldwide. Azenta maintains a robust global presence, with significant market share in North America, Europe (including the U.K. and Rest of Europe), Asia-Pacific, and China. Laboratories, biorepositories, and manufacturing facilities span these regions, enabling efficient service to international customers while employing around 3,300 professionals. This strategic footprint underscores Azenta's commitment to fostering breakthroughs in life sciences on a global scale

Azenta Inc. in the News:-

2026-05-21 - Azenta Publishes 2025 Environmental, Social, and Governance (ESG) Report
2026-05-05 - Azenta Reports Second Quarter Results for Fiscal 2026, Ended March 31, 2026, Updates Full Year Fiscal 2026 Guidance, and Extends Long-Range Plan to 2029
2025-07-31 - Azenta Life Sciences Partners with Frenova, a Division of Fresenius Medical Care, and Nephronomics to Advance Genomic Research in Nephrology
2025-01-30 - Azenta Announces the Election of Dipal Doshi to its Board of Directors
2025-01-23 - UK Biocentre Selects the Azenta Life Sciences BioArc Ultra Automated Storage System to Advance Research Excellence


Scope

• Tactical Analysis:- Various strategic frameworks to gain insights into a Azenta Inc.'s competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
• Business Strategy:- Contributes to shaping the Azenta Inc.'s overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
• Financial Position:- Provide valuable information on the financial performance and investor sentiment surrounding the company. Indicating the level of confidence and expectations in the company's future prospects. These components collectively contribute to understanding the financial health and market perception of the company.
• Company Fundamentals:- These fundamentals offer valuable insights into the company's history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
• Competitive Landscape:- An identification of the Azenta Inc.'s main competitors, providing insights into the competitive landscape it operates in.

Reasons to Buy

• Comprehensive Understanding of the Azenta Inc.'s internal and external factors through SWOT analysis, Financial Analysis, and Competitors Benchmarking.
• Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
• Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
• Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
• Financial Performance Evaluation provides crucial insights into key financial ratios and trends, supporting better financial decision-making and resource allocation.
• Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.

Additionally, available deep-dive analysis on the company Azenta Inc.:

• Azenta Inc. PESTLE Analysis
• Azenta Inc. Value Chain Analysis
• Azenta Inc. Porter's Five Forces Analysis
• Azenta Inc. VRIO Analysis
• Azenta Inc. BCG Analysis
• Azenta Inc. Segmentation, Targeting and Positioning (STP) Analysis
• Azenta Inc. Ansoff Matrix Analysis

ページTOPに戻る


Table of Contents

Table of Contents 2
Tables 5
Charts 6
Azenta Inc. - Key Company Facts 7
Azenta Inc. - Company Description 8
Azenta Inc. - Top Executives 9
Azenta Inc. - Head Office & Locations 10
Head Office - Country 10
Azenta Inc. - Products and Services 11
Products 11
Services 12
Azenta Inc. - Corporate Strategy 13
Azenta Inc. - Business Description 17
Sample Management Solutions 17
Multiomics 18
Azenta Inc. - ESG Spotlight 20
Environment 20
Social 21
Corporate Governance 22
Azenta Inc. - SWOT Analysis 24
Overview 24
Strengths 26
Weaknesses 29
Opportunities 31
Threats 32
Azenta Inc. - Financial Deep Dive 34
Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 34
Profit and Loss Statement 36
Summary of Profit and Loss Statement 36
Balance Sheet 40
Summary of Balance Sheet 40
Cash Flow Statement 44
Summary of Cash Flow Statement 44
Key Financial Ratio Analysis 48
Azenta Inc. - Ratio Charts 50
Activity Ratio Charts 50
Growth Ratios Charts 51
Leverage Ratio Charts 55
Liquidity Ratio Charts 57
Profitability Ratio Charts 59
Competing Players 61
Snapshot of Competing Players 62
Eurofins Scientific SE 62
Key Company Facts 62
Company Description 62
Key Financials 63
Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 63
Key Financial Ratio Analysis 68
Laboratory Corporation of America Holdings 70
Key Company Facts 70
Company Description 70
Key Financials 71
Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 71
Key Financial Ratio Analysis 76
Thermo Fisher Scientific Inc 78
Key Company Facts 78
Company Description 78
Thermo Fisher Scientific Inc. - SWOT Spotlight 79
Thermo Fisher Scientific Inc. - PESTLE Spotlight 81
Key Financials 83
Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 83
Key Financial Ratio Analysis 88
GenScript Biotech Corporation 90
Key Company Facts 90
Company Description 90
Key Financials 91
Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 91
Key Financial Ratio Analysis 96
BGI Genomics Co Ltd 98
Key Company Facts 98
Company Description 98
Key Financials 99
Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 99
Key Financial Ratio Analysis 104
Azenta Inc. - In the News 106
31-Jul-2025 - Azenta Life Sciences Partners with Frenova, a Division of Fresenius Medical Care, and Nephronomics to Advance Genomic Research in Nephrology 106
Azenta Inc. - Key Deals 108
04-Jun-2025 - Azenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical Research 108
13-May-2025 - Azenta Life Sciences and Form Bio Announce Strategic Partnership to Advance AAV Gene Therapy Development 109
Appendix 110
Definitions 110
SWOT Analysis 110
PESTLE Analysis 110
Value Chain Analysis 110
ESG Spotlight 110
Financial Deep Dive 110
Financial Ratios 111
Activity Ratios 111
Growth Ratios 113
Leverage Ratios 116
Liquidity Ratios 118
Market Ratios 120
Profitability Ratios 122
Research Methodology 124
Disclaimer 125
Contact Us 125

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療/ヘルスケア)の最新刊レポート

Quaintel Research社の 医薬品・医療分野 での最新刊レポート

本レポートと同じKEY WORD(corporate)の最新刊レポート


よくあるご質問


Quaintel Research社はどのような調査会社ですか?


Quaintel Researchはインドを拠点をとする調査会社です。 様々な企業の分析を行っており、企業の競合分析に役立つ資料をご提供します。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。


詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

 

2026/08/17 10:26

160.11 円

185.73 円

219.67 円

ページTOPに戻る